TABLE 1.
Receptora | Referenceb |
---|---|
Tyrosine kinase receptors | |
c-Fms | 163 |
c-Kit | 1 |
EGF-R | 12, 86 |
Flk-2 | 33 |
IGF-1-R | 152 |
Insulin-R | 151 |
PDGF-R | 12 |
TrkA | 90 |
Receptors signaling via the Syk/Zap70 family | |
BCR | 10 |
CD28 | 3, 104 |
FcγRI | 69 |
FcɛRI | 86 |
FcγRII | 69 |
FcγRIII | 160 |
Integrins | 21 |
NK complexc | 5 |
TCR | 12, 86 |
Receptor signaling via the Src family | |
CD19 | 154 |
Receptors signaling via the Jak family | |
c-Mpl | 31, 100, 102, 130 |
Epo-R | 84 |
G-CSF-R | 164 |
GM-CSF-R | 89 |
IL-2-R | 34 |
IL-3-R | 89 |
IL-5-R | 132 |
IL-6-R | 78 |
Prolactin R | 76 |
Type I IFN-R | 119 |
Receptors with uncharacterized kinases | |
CD14 | 47 |
CD2 | 121 |
CD40 | 110 |
CD43 | 115 |
CD5 | 49 |
G-coupled receptors | |
PAR1 | 22 |
Thrombin-R | 21 |
Receptors shown to phosphorylate Vav3 are underlined. IGF, insulin growth factor; IFN, interferon; PAR, protease-activated receptor.
For simplicity, only the first articles reporting the participation of Vav in a particular receptor pathway are included.
The receptor for the cytotoxic response of NK cells has not been identified yet. It is possible that it is not a single molecular entity but rather a set of membrane proteins (79).